Patient group and variable | No of potentially eligible patients | Treated | |||||||||||
All | Paxlovid | Sotrovimab | Remdesivir | Molnupiravir | Casirivimab/imdevimab | ||||||||
No | % (95% CI) | No | % (95% CI) | No | % (95% CI) | No | % (95% CI) | No | % (95% CI) | No | % (95% CI) | ||
All | 93 870 | 19 040 | 20 (20 to 21) | 4680 | 25 (24 to 25) | 9660 | 51 (50 to 51) | 30 | 0 (0 to 0) | 4620 | 24 (24 to 25) | 50 | 0 (0 to 0) |
Age band (years) | |||||||||||||
12-29 | 7610 | 1270 | 17 (16 to 18) | 310 | 24 (22 to 27) | 630 | 50 (47 to 52) | <8 | — | 320 | 25 (23 to 28) | 10 | 1 (0 to 1) |
30-39 | 10 640 | 2320 | 22 (21 to 23) | 630 | 27 (25 to 29) | 1150 | 50 (48 to 52) | <8 | — | 530 | 23 (21 to 25) | 10 | 0 (0 to 1) |
40-49 | 14 420 | 3280 | 23 (22 to 23) | 870 | 27 (25 to 28) | 1650 | 50 (49 to 52) | <8 | — | 740 | 23 (21 to 24) | 10 | 0 (0 to 0) |
50-59 | 18 900 | 4260 | 23 (22 to 23) | 1120 | 26 (25 to 28) | 2150 | 50 (49 to 52) | <8 | — | 980 | 23 (22 to 24) | 10 | 0 (0 to 0) |
60-69 | 17 760 | 3740 | 21 (20 to 22) | 900 | 24 (23 to 25) | 1970 | 53 (51 to 54) | <8 | — | 860 | 23 (22 to 24) | 10 | 0 (0 to 0) |
70-79 | 15 810 | 3040 | 19 (19 to 20) | 670 | 22 (21 to 24) | 1580 | 52 (50 to 54) | <8 | — | 780 | 26 (24 to 27) | <8 | — |
≥80 | 8720 | 1130 | 13 (12 to 14) | 180 | 16 (14 to 18) | 520 | 46 (43 to 49) | <8 | — | 420 | 37 (34 to 40) | <8 | — |
Sex | |||||||||||||
Female | 53 680 | 11 360 | 21 (21 to 22) | 2990 | 26 (26 to 27) | 5690 | 50 (49 to 51) | 20 | 0 (0 to 0) | 2640 | 23 (22 to 24) | 20 | 0 (0 to 0) |
Male | 40 190 | 7680 | 19 (19 to 19) | 1690 | 22 (21 to 23) | 3970 | 52 (51 to 53) | 10 | 0 (0 to 0) | 1980 | 26 (25 to 27) | 30 | 0 (0 to 1) |
Unknown | <8 | <8 | — | <8 | — | <8 | — | <8 | — | <8 | — | <8 | — |
Ethnic group | |||||||||||||
White | 82 770 | 17 450 | 21 (21 to 21) | 4330 | 25 (24 to 25) | 8870 | 51 (50 to 52) | 20 | 0 (0 to 0) | 4180 | 24 (23 to 25) | 40 | 0 (0 to 0) |
Asian or Asian British | 3840 | 660 | 17 (16 to 18) | 130 | 20 (17 to 23) | 370 | 56 (52 to 60) | <8 | — | 160 | 24 (21 to 28) | <8 | — |
Black or Black British | 2910 | 320 | 11 (10 to 12) | 70 | 22 (17 to 26) | 140 | 44 (38 to 49) | <8 | — | 100 | 31 (26 to 36) | <8 | — |
Mixed | 1180 | 180 | 15 (13 to 17) | 30 | 17 (11 to 22) | 90 | 50 (43 to 57) | <8 | — | 60 | 33 (26 to 40) | <8 | — |
Other ethnic groups | 1030 | 190 | 18 (16 to 21) | 40 | 21 (15 to 27) | 100 | 53 (46 to 60) | <8 | — | 60 | 32 (25 to 38) | <8 | — |
Unknown | 2150 | 220 | 10 (9 to 12) | 80 | 36 (30 to 43) | 80 | 36 (30 to 43) | <8 | — | 60 | 27 (21 to 33) | <8 | — |
Index of multiple deprivation group (divided by quintiles) | |||||||||||||
1 (most deprived) | 15 710 | 2290 | 15 (14 to 15) | 460 | 20 (18 to 22) | 1250 | 55 (53 to 57) | <8 | — | 570 | 25 (23 to 27) | <8 | — |
2 | 17 520 | 3220 | 18 (18 to 19) | 710 | 22 (21 to 23) | 1650 | 51 (50 to 53) | <8 | — | 850 | 26 (25 to 28) | 10 | 0 (0 to 1) |
3 | 19 960 | 4350 | 22 (21 to 22) | 1000 | 23 (22 to 24) | 2240 | 51 (50 to 53) | <8 | — | 1090 | 25 (24 to 26) | 10 | 0 (0 to 0) |
4 | 19 390 | 4260 | 22 (21 to 23) | 1150 | 27 (26 to 28) | 2090 | 49 (48 to 51) | <8 | — | 1010 | 24 (22 to 25) | 10 | 0 (0 to 0) |
5 (least deprived) | 18 730 | 4390 | 23 (23 to 24) | 1220 | 28 (26 to 29) | 2170 | 49 (48 to 51) | 10 | 0 (0–0) | 990 | 23 (21 to 24) | 10 | 0 (0 to 0) |
Unknown | 2560 | 520 | 20 (19 to 22) | 140 | 27 (23 to 31) | 260 | 50 (46 to 54) | <8 | — | 120 | 23 (19 to 27) | <8 | — |
Rurality | |||||||||||||
Urban—conurbation | 21 280 | 3450 | 16 (16 to 17) | 690 | 20 (19 to 21) | 2010 | 58 (57 to 60) | <8 | — | 740 | 21 (20 to 23) | <8 | — |
Urban—city and town | 48 840 | 10 040 | 21 (20 to 21) | 2540 | 25 (24 to 26) | 4800 | 48 (47 to 49) | 10 | 0 (0 to 0) | 2650 | 26 (26 to 27) | 30 | 0 (0 to 0) |
Rural—town and fringe | 12 460 | 2860 | 23 (22 to 24) | 740 | 26 (24 to 27) | 1470 | 51 (50 to 53) | <8 | — | 640 | 22 (21 to 24) | <8 | — |
Rural—village and dispersed | 8830 | 2170 | 25 (24–to 25) | 570 | 26 (24 to 28) | 1120 | 52 (50 to 54) | <8 | — | 480 | 22 (20 to 24) | <8 | — |
Unknown | 2470 | 510 | 21 (19 to 22) | 130 | 25 (22 to 29) | 260 | 51 (47 to 55) | <8 | — | 120 | 24 (20 to 27) | <8 | — |
Region | |||||||||||||
East Midlands | 16 150 | 3560 | 22 (21 to 23) | 1070 | 30 (29 to 32) | 2080 | 58 (57 to 60) | <8 | — | 390 | 11 (10 to 12) | 20 | 1 (0 to 1) |
East of England | 23 160 | 5760 | 25 (24 to 25) | 1050 | 18 (17 to 19) | 2970 | 52 (50 to 53) | 10 | 0 (0 to 0) | 1700 | 30 (28 to 31) | 20 | 0 (0 to 0) |
London | 4880 | 890 | 18 (17 to 19) | 190 | 21 (19 to 24) | 390 | 44 (41 to 47) | <8 | — | 310 | 35 (32 to 38) | <8 | — |
North East | 4390 | 710 | 16 (15 to 17) | 120 | 17 (14 to 20) | 490 | 69 (66 to 72) | <8 | — | 100 | 14 (12 to 17) | <8 | — |
North West | 8940 | 1720 | 19 (18 to 20) | 520 | 30 (28 to 32) | 870 | 51 (48 to 53) | <8 | — | 340 | 20 (18 to 22) | <8 | — |
South East | 6820 | 1370 | 20 (19 to 21) | 450 | 33 (30 to 35) | 600 | 44 (41 to 46) | <8 | — | 330 | 24 (22 to 26) | <8 | — |
South West | 13 850 | 2790 | 20 (19 to 21) | 590 | 21 (20 to 23) | 1270 | 46 (44 to 47) | <8 | — | 920 | 33 (31 to 35) | <8 | — |
West Midlands | 3180 | 590 | 19 (17 to 20) | 70 | 12 (9 to 14) | 450 | 76 (73 to 80) | <8 | — | 70 | 12 (9 to 14) | <8 | — |
Yorkshire and the Humber | 12 320 | 1600 | 13 (12 to 14) | 600 | 38 (35 to 40) | 540 | 34 (31 to 36) | <8 | — | 460 | 29 (27 to 31) | <8 | — |
Unknown | 180 | 40 | 22 (16 to 28) | 20 | 50 (35 to 65) | 20 | 50 (35 to 65) | <8 | — | <8 | — | <8 | — |
Additional clinical risk groups | |||||||||||||
Autism | 560 | 130 | 23 (20 to 27) | 30 | 23 (16 to 30) | 60 | 46 (38 to 55) | <8 | — | 40 | 31 (23 to 39) | <8 | — |
Care home resident | 3400 | 220 | 6 (6 to 7) | 50 | 23 (17 to 28) | 40 | 18 (13 to 23) | <8 | — | 130 | 59 (53 to 66) | <8 | — |
Dementia | 2180 | 140 | 6 (5 to 7) | 20 | 14 (8 to 20) | 50 | 36 (28 to 44) | <8 | — | 70 | 50 (42 to 58) | <8 | — |
Learning disability | 2750 | 540 | 20 (18 to 21) | 160 | 30 (26 to 33) | 190 | 35 (31 to 39) | <8 | — | 180 | 33 (29 to 37) | <8 | — |
Serious mental illness | 1170 | 190 | 16 (14 to 18) | 30 | 16 (11 to 21) | 100 | 53 (46 to 60) | <8 | — | 60 | 32 (25 to 38) | <8 | — |
Housebound | 2420 | 480 | 20 (18 to 21) | 100 | 21 (17 to 24) | 210 | 44 (39 to 48) | <8 | — | 160 | 33 (29 to 38) | <8 | — |
Clinically extremely vulnerable | 49 580 | 12 790 | 26 (25 to 26) | 2730 | 21 (21 to 22) | 6860 | 54 (53 to 54) | 20 | 0 (0–0) | 3160 | 25 (24 to 25) | 40 | 0 (0 to 0) |
Sickle cell disease | 990 | 100 | 10 (8 to 12) | 40 | 40 (30 to 50) | 30 | 30 (21 to 39) | <8 | — | 30 | 30 (21 to 39) | <8 | — |
Vaccination status | |||||||||||||
Unvaccinated (refused) | 1090 | 80 | 7 (6 to 9) | 20 | 25 (16 to 34) | 40 | 50 (39 to 61) | <8 | — | 20 | 25 (16 to 34) | <8 | — |
Unvaccinated | 3190 | 260 | 8 (7 to 9) | 50 | 19 (14 to 24) | 120 | 46 (40 to 52) | <8 | — | 80 | 31 (25 to 36) | <8 | — |
One vaccination | 2120 | 270 | 13 (11 to 14) | 70 | 26 (21 to 31) | 130 | 48 (42 to 54) | <8 | — | 60 | 22 (17 to 27) | <8 | — |
Two vaccinations | 10 000 | 1090 | 11 (10 to 12) | 200 | 18 (16 to 21) | 550 | 50 (47 to 53) | <8 | — | 330 | 30 (28 to 33) | 10 | 1 (0 to 1) |
Three or more vaccinations | 77 470 | 17 350 | 22 (22 to 23) | 4340 | 25 (24 to 26) | 8820 | 51 (50 to 52) | 20 | 0 (0 to 0) | 4130 | 24 (23 to 24) | 40 | 0 (0 to 0) |
Patient numbers of 0-7 are shown as <8, with remaining numbers rounded to the nearest 10; as a result percentages might not add up to 100%.